Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis
Clinical trial NCT03622658 · COMPLETED
Trial details
- NCT number
- NCT03622658
- Sponsor
- Izana Bioscience Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-06
- Primary completion
- 2020-02-04
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.